| Title: | END OF INCREASED SURVEILLANCE OF FDA-REGULATED PRODUCTS FROM TIANJIN, CHINA |
|---|---|
| Date: | 2016-07-06 |
| To: | abi,edi,partner |
| Links: | previous, original, next |
FDA is issuing this communication as notification of the end of FDA's increased surveillance of certain FDA-regulated products imported from the industrial center Binhai New Area in Tianjin, China, and Xiditou Township of Beichen District in Tianjin, China.
FDA has returned to routine surveillance of FDA-regulated products from this region.
Questions regarding this action by FDA can be directed to Division of Import Operations, 12420 Parklawn Drive, ELEM Room 3109, Rockville, MD 20857 telephone: (301) 796-0356.